Aduro BioTech, Inc. (ADRO)


Stock Price Forecast

Oct. 5, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aduro BioTech, Inc. chart...

About the Company

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.

Sector

Health Technology

Industry

Biotechnology

Employees

96

CEO

Stephen T. Isaacs

Exchange

NASDAQ

Website

http://www.aduro.com

$3B

Total Revenue

96

Employees

$502B

Market Capitalization

1459.50

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ADRO News

Aduro Biotech, Merck Team on Cancer Drug Trial

6y ago, source: TheStreet.com

Aduro Biotech and Merck will team on two separate trials featuring Aduro's CRS-207 and Merck's Keytruda to explore treatments for mesothelioma and gastric cancer. Aduro Biotech and Merck will team ...

Aduro Biotech Pancreatic Cancer Immunotherapy Fails Mid-Stage Study

7y ago, source: TheStreet.com

A type of common bacteria re-engineered by Aduro Biotech to engage the immune system to kill pancreatic cancer failed a mid-stage study, the company announced Monday. A type of common bacteria re ...

Aduro BioTech

1mon ago, source: OpenSecrets.org

H.R. 2397, Department of Defense Appropriations Act, 2014, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines. HR 933, Consolidated and Further Continuing ...

Lobbying Firm Profile: Innovative Federal Strategies

27d ago, source: OpenSecrets.org

Aduro BioTech Innovative Federal Strategies FIRST QUARTER (NO ACTIVITY ... CA Innovative Federal Strategies THIRD QUARTER REPORT $10,000 Cray Inc Innovative Federal Strategies FIRST QUARTER REPORT $30 ...

Aduro Clean Technologies Inc.

2y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Biotech Rally Gets $100 Billion M&A Lift With More Deals to Come

on MSN ago, source:

A rash of dealmaking helped reverse the declining fortunes of biotech stocks over the last five months. And as AstraZeneca ...

This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery

3d ago, source: 24/7 Wall St on MSN

With the pandemic largely in the rear-view mirror, vaccine maker Novavax has seen shares fall. Yet, analysts have high hopes ...

Pharmala Biotech Holdings Inc MDMA

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

How biotech crops will enhance human and environmental health in Nigeria

3h ago, source: Nigerian Tribune on MSN

OVER the years, farmers in Nigeria have struggled with crop loss due to insect and pest attacks. This has resulted in significant financial losses for many farmers, causing frustration and driving ...

PRTG Portage Biotech Inc.

4d ago, source: Seeking Alpha

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment ...

Krystal Biotech, Inc. (KRYS)

21d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Aduro Clean Technologies Inc Ordinary Shares

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...